Taken together, the above findings demonstrated that FXR is positively correlated with the expression of IL-6, IL-6ST and p-STAT3 (Tyr705), and this is indicative of a poor prognosis in NSCLC patients. The gene discussed is IL6; the disease is non-small cell lung carcinoma.